MiR-34b is associated with clinical outcome in triple-negative breast cancer patients - Wikidata - wikimedia - TriplyDB

MiR-34b is associated with clinical outcome in triple-negative breast cancer patients

MiR-34b is associated with clinical outcome in triple-negative breast cancer patients

http://www.wikidata.org/entity/Q35950656

about

MiRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast Cancer MicroRNAs and triple negative breast cancer Decoding the usefulness of non-coding RNAs as breast cancer markers Identification of Specific miRNA Signature in Paired Sera and Tissue Samples of Indian Women with Triple Negative Breast Cancer Low Expression of Circulating MicroRNA-34c is Associated with Poor Prognosis in Triple-Negative Breast Cancer MicroRNAs in the prognosis of triple-negative breast cancer: A systematic review and meta-analysis A prognostic model of triple-negative breast cancer based on miR-27b-3p and node status Circulating miRNAs as new blood-based biomarkers for solid cancers.Identifying microRNAs regulating B7-H3 in breast cancer: the clinical impact of microRNA-29c.High expression of miR-214 is associated with a worse disease-specific survival of the triple-negative breast cancer patients.Critical analysis of the potential for microRNA biomarkers in breast cancer management.Increased microRNA-34b and -34c predominantly expressed in stromal tissues is associated with poor prognosis in human colon cancer.Improving the differential diagnosis between myelodysplastic syndromes and reactive peripheral cytopenias by multiparametric flow cytometry: the role of B-cell precursors.Decreased expression of microRNA-124 is an independent unfavorable prognostic factor for patients with breast cancer.Prognostic significance of MiR-34a in solid tumors: a systemic review and meta-analysis with 4030 patients.The ectopic expression of BRCA1 is associated with genesis, progression, and prognosis of breast cancer in young patients miR-34b inhibits nasopharyngeal carcinoma cell proliferation by targeting ubiquitin-specific peptidase 22 The orphan nuclear receptor NR4A2 is part of a p53-microRNA-34 network.A single-nucleotide polymorphism in the 3'-UTR region of the adipocyte fatty acid binding protein 4 gene is associated with prognosis of triple-negative breast cancer.MicroRNA-34a suppresses cell proliferation by targeting LMTK3 in human breast cancer mcf-7 cell line.Clinicopathologic features of triple negative breast cancers: an experience from Pakistan.microRNAs: a new class of breast cancer biomarkers.The role of miRNAs in cancer: from pathogenesis to therapeutic implications.The genetic association between pri-miR-34b/c polymorphism (rs4938723 T > C) and susceptibility to cancers: evidence from published studies.MicroRNA expressions associated with progression of prostate cancer cells to antiandrogen therapy resistance.Downregulated circulating microRNAs after surgery: potential noninvasive biomarkers for diagnosis and prognosis of early breast cancer

P2860

Q26775086-F2722F7D-11B4-4EBA-B209-D9596FDC047C Q26862716-8FB60B69-79C4-4E9B-811F-32F45F3E88A9 Q28069370-33A06FF9-C319-457A-87BA-438C94BC579A Q28552581-4A7B2AF3-26DF-4646-9824-527528BE24DC Q33734951-F3B32518-2A7D-4BD2-A043-3E4A9BD4EC07 Q33765619-DF3236D9-43DD-44AF-A5B1-64638B9BCF7E Q33779774-D61DBB36-9E0C-41CF-812F-3B55AD88DAC0 Q34331651-A88E17E3-0527-4E4B-B9A7-85CE9DDC7ED5 Q35104159-47A7EC1C-B7E7-4590-B517-FFF299EA2CA0 Q35105646-1C38B3E8-E8DB-4D51-8BA0-802F07412F57 Q35137273-28EC9D68-0B0B-44F8-8FC9-03D714C8EC07 Q35496606-0BBD7270-1DA9-4519-8386-7E398B43FC8E Q35596082-F35C481C-E11E-426F-A7FF-026281F3F506 Q35601474-E6AF98CC-6991-40E2-BA1D-7C9EC020A23E Q36411504-132D7769-BFE6-4C7C-AF46-C49F8CCDD6BD Q36521293-EB79FD2B-C5C6-4213-9C5E-6D4BA0C9C4D3 Q36716288-BFE7FA32-32ED-4B23-A44C-E46B6C992EFD Q36845699-4C5F5511-1939-444A-92A4-A9053059DB51 Q37109912-25B0631F-0C38-45D8-891D-008F4DDC9B0E Q37395296-CE32EA6B-8E07-4444-AB24-03750ADB2E15 Q37717271-3090C5EE-339E-4F0C-93E0-51222EF7B1CF Q38197675-308FB310-30E0-420D-A2A7-D90DB124BE5A Q38221290-77FB6A3D-9732-47F0-AD1E-7FC4CF901748 Q38395205-85130EEF-5F77-432C-936C-A30DBFA880E9 Q39037653-F5EB9A07-95E0-40B4-ABA4-BC2214FC56F5 Q58799732-EEBA4690-B675-438C-BB37-6AF3261858F0

P2860

MiR-34b is associated with clinical outcome in triple-negative breast cancer patients

http://www.wikidata.org/entity/Q35950656

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

MiR-34b is associated with clinical outcome in triple-negative breast cancer patients

@ast

MiR-34b is associated with clinical outcome in triple-negative breast cancer patients

@en

type

label

MiR-34b is associated with clinical outcome in triple-negative breast cancer patients

@ast

MiR-34b is associated with clinical outcome in triple-negative breast cancer patients

@en

prefLabel

MiR-34b is associated with clinical outcome in triple-negative breast cancer patients

@ast

MiR-34b is associated with clinical outcome in triple-negative breast cancer patients

@en

P1433

Q35950656-A113AF4B-8BC9-4830-BE37-1153798076E3

P1476

Q35950656-4EDE1F51-47EC-4C93-AFE6-A8938BC5279F

P2093

Q35950656-05283E74-EC9C-4BBC-8673-BF9E844C74B3

Q35950656-1E0D356E-10EB-4399-BA3E-4D1B8DBB832B

Q35950656-3A87F25E-D05D-43D1-B1EF-A05713CC56B6

Q35950656-3B92BE99-04E2-47FC-AEBF-E6B2DB47CE44

Q35950656-49C888BC-AFFA-4EDF-9067-A387BBE71886

Q35950656-8C14B8C0-B91F-44E7-8E6C-3A95970D6058

Q35950656-99366044-3FB3-435B-8DCA-779994EB6AC1

Q35950656-C5EEA23E-DD86-41D3-842F-A815B4608067

P2860

Q35950656-02FAEC1A-FE19-44C2-875F-55094A4CD43E

Q35950656-032081EA-37B3-4741-AE19-E8ECA76B70E3

Q35950656-052AD9E6-96C6-491F-B3D2-3F18DB11E3D7

Q35950656-0B792CFD-0A29-4B32-8F69-0625AEC47752

Q35950656-0D07F1E7-4405-4C48-94B4-0A405E05BCF0

Q35950656-11A2EA1F-DA8B-46DC-80FF-56F02CCC3D6F

Q35950656-12C3711C-58E8-4B30-9F9E-A6C683AAB870

Q35950656-1E544161-AADB-45BA-B41B-9865263E4F54

Q35950656-31845ADA-35E1-4835-8E37-FACD046A679F

Q35950656-38088991-6DA7-4119-A8F9-61E9CDC6A453

P2888

Q35950656-6AE13121-585C-45B4-B44E-4687C275047C

P304

Q35950656-FCFF9A25-46FF-4601-8924-F5AD87DA9BF7

P31

Q35950656-6F32A5DC-8FC2-459F-9B93-FF4563566B8F

P356

Q35950656-0E1A6816-8E87-45C7-8814-46E047C5B90B

P478

Q35950656-7ED1C3F8-2809-4F22-AD8B-3C08DE40FFBF

P577

Q35950656-3A8E0B42-6DB6-4D9D-BE84-24C01A57B785

P5875

Q35950656-D55774E5-AB04-4ED4-B1A6-9D11EB6A9DC9

P6179

Q35950656-A8943E7F-7AB3-48B3-84C0-8E71E02CFC33

P698

Q35950656-1A5E142D-7F6C-4FBC-968A-4E1AC76111DC

P932

Q35950656-3BC7D4BD-BA8E-4224-9F09-AE96AA959B9A

P356

P1433

Diagnostic Pathology

P1476

MiR-34b is associated with clinical outcome in triple-negative breast cancer patients

@en

P2093

Jiri Navratil

http://www.w3.org/2001/XMLSchema#string

Jiri Sana

http://www.w3.org/2001/XMLSchema#string

Marek Svoboda

http://www.w3.org/2001/XMLSchema#string

Marketa Palacova

http://www.w3.org/2001/XMLSchema#string

Martina Redova

http://www.w3.org/2001/XMLSchema#string

Ondrej Slaby

http://www.w3.org/2001/XMLSchema#string

Pavel Fabian

http://www.w3.org/2001/XMLSchema#string

Rostislav Vyzula

http://www.w3.org/2001/XMLSchema#string

P2860

A microRNA component of the p53 tumour suppressor network

Frequent downregulation of miR-34 family in human ovarian cancers.

MiR-34a expression has an effect for lower risk of metastasis and associates with expression patterns predicting clinical outcome in breast cancer.

Down-regulation of BRCA1 expression by miR-146a and miR-146b-5p in triple negative sporadic breast cancers.

MiR-34, SIRT1 and p53: the feedback loop.

Breast cancer - one term, many entities?

miRNA-34b as a tumor suppressor in estrogen-dependent growth of breast cancer cells.

MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy.

Notch2 signaling induces apoptosis and inhibits human MDA-MB-231 xenograft growth.

Triple-negative breast cancer: therapeutic options.

P2888

P304

31

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1746-1596-7-31

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2012-03-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221968670

http://www.w3.org/2001/XMLSchema#string

P6179

1031205920

http://www.w3.org/2001/XMLSchema#string

P698

22439831

http://www.w3.org/2001/XMLSchema#string

P932

3349474

http://www.w3.org/2001/XMLSchema#string